Literature DB >> 17284382

Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS.

Timothy M Zagar1, Richard G Stock, Jamie A Cesaretti, Nelson N Stone.   

Abstract

PURPOSE: This study is to compare the Mount Sinai Erectile Function Score (MSEFS), our brachytherapy program's physician-assigned scale, with patients' independently completed International Index of Erectile Function-5 (IIEF-5). METHODS AND MATERIALS: A total of 1202 patients with T1-T3 prostate cancer were treated with ultrasound-guided radioactive seed implantation +/- EBRT with at least one visit where both MSEFS and IIEF-5 were completed. Spearman rho correlations were performed.
RESULTS: The MSEFS significantly correlated with the total IIEF-5 scores on all comparisons. The coefficient was 0.65 for comparisons at initial consultation and 0.76 for all visits. The correlations remained strong, averaging to 0.76 for visits 1 through 10.
CONCLUSIONS: In assessing erectile dysfunction after radiation, the MSEFS correlates well with, but cannot be replaced by, the IIEF-5, which is weighted toward one's degree of sexual desire. More insight into patients' erectile function after brachytherapy may be gotten if the IIEF-15 is used instead of the IIEF-5 with our MSEFS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284382     DOI: 10.1016/j.brachy.2006.11.003

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  3 in total

1.  Five-year potency preservation after iodine-125 prostate brachytherapy.

Authors:  Shuichi Nishimura; Atsunori Yorozu; Toshio Ohashi; Masanori Sakayori; Yasuto Yagi; Toru Nishiyama; Shiro Saito; Yutaka Shiraishi; Kayo Yoshida; Kazuhito Toya; Naoyuki Shigematsu
Journal:  Int J Clin Oncol       Date:  2013-10-31       Impact factor: 3.402

2.  A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.

Authors:  Sarah L Kerns; Richard Stock; Nelson Stone; Michael Buckstein; Yongzhao Shao; Christopher Campbell; Lynda Rath; Dirk De Ruysscher; Guido Lammering; Rosetta Hixson; Jamie Cesaretti; Mitchell Terk; Harry Ostrer; Barry S Rosenstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-26       Impact factor: 7.038

3.  Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study.

Authors:  Frank Peinemann; Alexander Michael Labeit; Christian Thielscher; Michael Pinkawa
Journal:  BMJ Open       Date:  2014-06-04       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.